Fortress Biotech, Inc.FBIONASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year revenue growth rate
Latest
7.42%
↓ 90% below average
Average (39q)
74.65%
Historical baseline
Range
High:1252.00%
Low:-345.03%
CAGR
-12.3%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 7.42% |
| Q2 2025 | 24.92% |
| Q1 2025 | -13.10% |
| Q4 2024 | 3.36% |
| Q3 2024 | -1.79% |
| Q2 2024 | 14.32% |
| Q1 2024 | -34.67% |
| Q4 2023 | -42.60% |
| Q3 2023 | 99.88% |
| Q2 2023 | 39.88% |
| Q1 2023 | -24.23% |
| Q4 2022 | -0.75% |
| Q3 2022 | -12.49% |
| Q2 2022 | -21.06% |
| Q1 2022 | 30.91% |
| Q4 2021 | -13.32% |
| Q3 2021 | 18.17% |
| Q2 2021 | 53.99% |
| Q1 2021 | -15.72% |
| Q4 2020 | 45.11% |
| Q3 2020 | 0.19% |
| Q2 2020 | -26.79% |
| Q1 2020 | 16.06% |
| Q4 2019 | 13.90% |
| Q3 2019 | 5.64% |
| Q2 2019 | 42.81% |
| Q1 2019 | 104.15% |
| Q4 2018 | -345.03% |
| Q3 2018 | -0.22% |
| Q2 2018 | 15.17% |
| Q1 2018 | 22.30% |
| Q4 2017 | -3.34% |
| Q3 2017 | -7.52% |
| Q2 2017 | 13.46% |
| Q1 2017 | 254.20% |
| Q4 2016 | 1193.85% |
| Q3 2016 | -56.28% |
| Q2 2016 | 237.88% |
| Q1 2016 | 95.27% |
| Q4 2015 | 1252.00% |